|1|Hyperuricemia and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis. (26545082)
Gong S.... Wang Y.
|2|Green tea polyphenol epigallocatechin-3-gallate ameliorates insulin resistance in non-alcoholic fatty liver disease mice. (25891086)
Gan L.... Li H.
|3|Nonalcoholic Fatty Liver Disease and Hyperuricemia: A Close Relation with Hepatic Insulin Resistance after Nicotinic Acid Treatment? (25350520)
Blond E.... Laville M.
|4|Acceleration training for managing nonalcoholic fatty liver disease: a pilot study. (25404857)
Oh S.... Shoda J.
|5|Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor I' activation. (23605066)
Li Q.... Zhu Z.
|6|Pediatric non-alcoholic fatty liver disease: an increasing public health issue. (24068459)
Berardis S.... Sokal E.
|7|miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. (22902550)
Castro R.E.... Rodrigues C.M.
|8|Simple noninvasive systems predict long-term outcomes of patients with nonalcoholic fatty liver disease. (23860502)
Angulo P.... George J.
|9|Oral probiotic microcapsule formulation ameliorates non-alcoholic fatty liver disease in Bio F1B Golden Syrian hamsters. (23554890)
Bhathena J.... Prakash S.
|10|The prevalence and clinical correlates of nonalcoholic fatty liver disease (NAFLD) in African Americans: the multiethnic study of atherosclerosis (MESA). (23546700)
Foster T.... Budoff M.
|11|Efficacy of Tumor Necrosis Factor and Interleukin-10 Analysis in the Follow-up of Nonalcoholic Fatty Liver Disease Progression. (24426199)
Zahran W.E.... El-Sawaby A.S.
|12|Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent. (23564467)
Palmer N.D.... Speliotes E.K.
|13|Abnormality of Autophagic Function and Cathepsin Expression in the Liver from Patients with Non-alcoholic fatty liver disease. (24299564)
Fukuo Y.... Watanabe S.
|14|IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice. (24115079)
Harley I.T.... Divanovic S.
|15|Expression of cytochrome P450 2A5 in a C57BL/6J mouse model of nonalcoholic fatty liver disease. (23867551)
Li R.... Zhang X.
|16|Coffee enhances the expression of chaperones and antioxidant proteins in rats with nonalcoholic fatty liver disease. (24365744)
Salomone F.... Galvano F.
|17|Blood urea nitrogen is elevated in patients with non-alcoholic fatty liver disease. (23858556)
Liu X.... Liang J.
|18|Association between liver-specific gene polymorphisms and their expression levels with nonalcoholic fatty liver disease. (23213074)
Adams L.A.... Pennell C.E.
|19|Treatment of non-alcoholic fatty liver disease: can we already face the epidemic? (23898557)
Verbeek J.... Nevens F.
|20|Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets. (23530957)
Giorgio V.... Nobili V.
|21|Chronic kidney disease and nonalcoholic Fatty liver disease proven by transient elastography. (24029696)
Mikolasevic I.... Orlic L.
|22|Analysis of cytotoxic T-lymphocyte-associated antigen-4 and MMP-9 genes' methylation and their expression profiles with risk of non-alcoholic fatty liver disease. (24019613)
Tamandani D.M.... Shafiepour S.
|23|Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF-I levels. (22077984)
Fusco A.... De Marinis L.
|24|Expression of MCP-1 in the patients of chronic hepatitis B complicated with nonalcoholic fatty liver disease]. (22980664)
Shen H.Y.... Xu Z.
|25|Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study. (20825652)
Dongiovanni P.... Valenti L.
|26|Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. (19523535)
Shah A.G.... Sanyal A.J.
|27|Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease. (18713296)
Ma H.... Xiao S.Y.
|28|The effect of metformin on leptin in obese patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease. (18839053)
Nar A.... Gedik O.
|29|Prescribing statins to patients with nonalcoholic fatty liver disease: real cardiovascular benefits outweigh theoretical hepatotoxic risk. (19555426)
Riley P.... Crook M.
|30|Efficacy and safety of ezetimibe/simvastatin combination therapy in patients with type 2 diabetes and nonalcoholic fatty liver disease]. (19443308)
Abel T.... KovA!cs A.
|31|The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in non alcoholic fatty liver disease. (19561788)
Polyzos S.A.... Zavos C.h.
|32|Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. (19524579)
Kotronen A.... Yki-JAorvinen H.
|33|The evolution of ideas about nonalcohol fatty liver disease]. (19967814)
|34|Abdominal adipose area, serum adiponectin and leptin levels of nonalcoholic fatty liver disease in elderly males.]. (19254460)
Tao T.... Zhao Y.J.
|35|Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. (19765850)
Abid A.... Assy N.
|36|Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C. (19515216)
Younossi Z.M.... Baranova A.
|37|Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. (18242210)
Fabbrini E.... Klein S.
|38|Peroxisome proliferator-activated receptor gamma: a common link for non-alcoholic fatty liver disease and colorectal cancer? (17482764)
Yavas O.... Eren O.O.
|39|The prevalence of peripheral iron overload and the presence of HFE gene (H63D) mutation among the Korean patients with nonalcoholic fatty liver disease]. (17585191)
Lee D.... Lee D.H.
|40|Methylenetetrahydrofolate reductase C677T mutation and nonalcoholic fatty liver disease. (17356914)
Serin E.... Yilmaz U.
|41|Gene expression patterns in hepatic tissue and visceral adipose tissue of patients with non-alcoholic fatty liver disease. (17953248)
Baranova A.... Younossi Z.M.
|42|Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease. (16911470)
Lydatakis H.... Diamantis I.
|43|Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. (16618517)
Haukeland J.W.... Aukrust P.
|44|In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. (16799979)
Wieckowska A.... Feldstein A.E.
|45|Nonalcoholic fatty liver disease in India--is it different? (17542290)
|46|Association between tumor necrosis factor-alpha gene polymorphism and insulin resistance in nonalcoholic fatty liver disease]. (16938178)
Huang J.... Zhou Y.J.
|47|Association of serum leptin and insulin resistance with nonalcoholic fatty liver disease]. (16793619)
Hu Z.W.... Deng X.L.
|48|The role of PPAR alpha in the pathogenesis of fatty liver disease]. (16174475)
Xu L.... Li Y.M.
|49|Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment. (16245220)
ErsAPz G.... Akarca U.S.
|50|Leptin and fatty liver disease]. (15329225)
Zhao C.Y.... Li L.